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Abstract
This paper proposes the hypothesis that genetic distance to the health frontier in￿ u-
ences population health outcomes. Evidence from a world sample suggests that genetic
distance￿ interpreted as long-term cultural and biological divergence￿ is an important factor
in understanding health inequalities across countries. In particular, the paper documents
a remarkably robust link between genetic distance and health as measured by life ex-
pectancy at birth and the adult survival rate. Also, the evidence reveals that the link has
strengthened considerably over the 20th century which highlights the increasing e⁄ects
of globalization on health conditions across countries through the transmission of health
technologies.
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While inequalities in mortality outcomes across countries in the last century were reduced,
considerable disparities persist even today.1 For example, life expectancy at birth in Sweden at
the start of the new millennium was 78 years whereas the corresponding ￿gure in Malawi was
only 51 years. What breeds this discrepancy in health across countries￿ the health gradient?
The current paper takes the health gradient as a puzzle to be examined and seeks to contribute
to a more profound understanding of the answer to this important and intriguing question.
In this paper, the focal point is on the di⁄usion of international health technologies in
the 20th century. On this, Preston (1975, p.237) has concluded that ￿factor exogenous to a
country￿ s current level of income probably account for 75-90 per cent of the growth in life
expectancy for the world as a whole between the 1930s and 1960s￿where the spread of health
technologies is thought of as exogenous￿ similar conclusions have been derived in other research
(see Deaton, 2004; Cutler et al., 2006; Soares, 2007).2
This paper hypothesizes that a country genetically closer to the health frontier bene￿ts
more from new health technologies, compared to countries genetically further away, in their
capability of di⁄using these technologies and thereby driving down mortality. To test the
hypothesis, I use a measure of genetic distance to the United States taken from Spolaore and
Wacziarg (2009). This variable can be interpreted as an aggregate measure of cultural and
biological long-term divergence to the US. Thus, the proposed hypothesis is based on the view
that divergence￿ especially culturally divergence￿ interacts with modern health technologies in
determining mortality outcomes. This observation is not new, for example, Caldwell (1990,
p.51) writes that ￿where the greatest success over mortality have been gained, this achievement
has been the product of an interaction between certain cultural and social characteristics on the
one hand and easy accessibility of basic modern health services on the other￿which, essentially,
elaborates my hypothesis in a nutshell. A somewhat similar point is made in Deaton (2004,
p.108): ￿today, the health of most people in the world, in rich as well as poor countries,
1See Becker et al. (2005) for a paper that documents convergences in life expectancy across countries.
2Table 6 in Appendix A, also reproduces the basic insight made in Preston (1975) for a wider group of
countries, over the 1960-2000 period, by demonstrating that time ￿xed e⁄ects explain the bulk of variation in
life expectancy at birth.
1depends on their ability to locally adopt health knowledge and health technologies that have
been discovered and developed and developed elsewhere￿ . The current hypothesis builds on
the presumption that this ability is in part captured by long-term divergence to elsewhere (the
health frontier). Also, the fact that many health technologies (knowledge) are realizable even
for poor countries today opens up a channel whereby long-term divergence may a⁄ect the health
gradient around the income channel.
The novelty of the current paper is to utilize genetic distance, as proposed by Spolaore
and Wacziarg (2009), to measure cultural divergence and to show that this variable is indeed
a powerful and robust determinant of the health gradient at the country level. For example,
the empirical analysis below demonstrates that a one-standard-deviation increase in genetic
distance to the US is associated with a 55.6% of a standard deviation decrease in the adult
survival rate, in the year 2000, controlling for a range of geographical, socioeconomic and
historical characters . Moreover, the analysis demonstrates that there was no e⁄ect of genetic
distance at the start of the 20th century. I take this as evidence for the proposed hypothesis
because the globalization and e¢ cacy of health and medical technologies were relatively limited
at that period of time.
These ￿ndings contribute to the literature in two important ways. First, the ￿ndings iden-
tify the e⁄ect of technological progress on population health. Because of identi￿cation issues,
such as reverse causality, this is a somewhat unexplored area (Bloom and Canning, 2007).
However, my study utilizes a variable￿ genetic distance￿ where this is not a concern, to show
that technological progress is indeed an essential determinant of the health gradient. Second,
my ￿ndings also add to discussion of how countries health conditions are a⁄ected by globaliza-
tion (Deaton, 2004). In fact, the empirical results provided here indirectly reveal that faster
transmission of health technologies (globalization) has a signi￿cant positive e⁄ect on population
health outcomes across countries.
This study relates to the research of Spolaore and Wacziarg (2009). Their focus is, however,
on how genetic distance explains variation in output per capita.3 In particular, they explain
3In an interesting contribution, Ashraf and Galor (2010b) study the relation between within country genetic
diversity and historic economic outcomes, as well as contemporary outcomes. The analysis reveals a U-shaped
relation which implies that one, in principle, can pinpoint an "optimal" level genetic diversity.
2their ￿nding of a negative e⁄ect of genetic distance on output per capita by the fact that long-
term divergence acts as a barrier to the di⁄usion of all technologies. This research supports
their ￿nding but suggests that a central mechanisms through which genetic distance in￿ uences
output negatively is the health channel as an intermediate.4 Put more schematically, I argue
that interaction between health technologies and cultural divergence ) health outcomes )
output per capita.
A complementarity hypothesis is proposed by Galor and Moav (2007). They argue persua-
sively that the timing of the transition from hunter-gather to agricultural society (the Neolithic
Revolution) is pivotal for contemporary inequality in life expectancy across countries. They
posit that the rise of agriculture launched the evolution of crowd infectious diseases through
more dense populations. This, in turn, produced an evolutionary advantage for descendants of
populations who made the agricultural transition early on. To support their hypothesis, they
regress the timing of the Neolithic Revolution, adjusted with post-1500 migration ￿ ows, on life
expectancy at birth in the year 2000 and they show that en earlier transition date is associated
with higher life expectancy. The hypothesis put forward here underscores the importance of
modern health technologies in symbiosis with long-term divergence. Crudely speaking, one can
parallel my hypothesis to sophisticated geography hypothesis, where, because of technological
drift, being genetically distant to the US has a contemporary adverse e⁄ect on health outcomes
whereas the hypothesis put forward by Galor and Moav (2007) is more based on evolutionary
biological line of thought.
The study by Papageorgiou et al. (2007) claim that non-health-frontier countries bene￿t
from health knowledge embodied in medical imports in terms of lower mortality rates. Impor-
tantly, though, I demonstrate that the relation between health and genetic distance is robust
to their argument which suggests that the in￿ uence of genetic distance on mortality outcomes
is not per se operating through medical imports and, more generally, openness to trade.
Other papers have studied determinants of life expectancy or mortality on potentially ex-
ogenous factors. Among them, Pritchett and Summers (1996) exploit exogenous variation in
income to determine the causal e⁄ect on various measures of health-status. They ￿nd a sig-
4Where the health channel is the strong cross-country correlation between output per capita and health
(Preston, 1975; Bloom and Canning, 2000, 2007)
3ni￿cant e⁄ect of income in reducing infant and child mortality but they ￿nd no e⁄ect on life
expectancy. These ￿ndings are also to some extent recovered in the present paper.
The remainder of the paper continues as follows. Section 2 elaborates on the hypothesis
and presents a theoretical model to facilitate the empirical analysis. Section 3 brie￿ y presents
the empirical framework. Section 4 outlines the assembled dataset. Section 5 and 6 give the
regressions results. Finally, section 7 concludes.
2 The hypothesis
This paper hypothesizes that genetic distance to the US, as a measure of long-term divergence,
behaves as barrier for the di⁄usion of international health and medical technologies (knowledge)
which is mirrored in population health outcomes.
There are several reasons to why this should be a reasonable hypothesis to test. Firstly, and
essential for the hypothesis, is what Vallin and MeslØ (2004) denote as the ￿health transition￿
which, broadly, refers to the international di⁄usion of new health technologies (shocks) where
the speed and di⁄usion depend on country speci￿c characteristics. In this regard, the authors
themselves emphasize culture as one important characteristic. The hypothesis here simply says
that this argument can, in part, be captured by cultural divergence to the health frontier.
Secondly, along similar lines, Caldwell (1980, 1990, 1992) argues that the interaction with
culture divergence to Western countries and health technologies is a strong determinant of the
mortality level in developing countries. For example, Caldwell (1992, p.213) concludes that
￿rapid mortality decline in the Third World depends on access to both modern curative and
preventive medicine and the fullest possible collaboration with these systems in both belief and
action￿and genetic distance may be viewed as an excellent summary of divergence in such
beliefs. In Caldwell (1990), he asserts that one persistent result, from various micro-studies,
is that there are major ethnic or cultural discrepancies in mortality even after controlling
for income and education. Caldwell (1980; 1992) also suggests that the strong correlation
between female education and child mortality, found in many studies (see e.g., Cleland and
van Ginneken, 1988), is because schooling produces a change in beliefs and behavior toward a
so-called ￿Western-system￿which he denotes as a deculturating experience.
4Thirdly, besides the cultural channel, there may also biological angle to the hypothesis as
well. While the topic is still debated, a branch of the biomedical literature has been arguing
that there exist disparities in drug responsiveness and e¢ cacy among di⁄erent ethnic and racial
groups within countries. For example, with respect to beta-blockers￿ which is used to treat heart
related conditions￿ African Americans respond less well compared to European Americans (Tate
and Goldstein, 2004). Similarly, Drake et al. (2008) claim that ￿there are well-documented
disparities among ethnic and racial groups with respect to asthma prevalence, mortality and
drug response￿ . Since, genetic distance, inevitably, correlates with this type of ethnic and racial
classi￿cation, a similar mechanism may be operating between countries. In other words, it is
hypothesized that, on average, populations genetically distant to the medical (health) frontier
may respond less well to new medicine because new medications are biased toward populations
living in the proximity of the health frontier￿ represented here by the US.
One implication of the current hypothesis is that there should be no health gradient in
genetic distance before the rise of modern health technologies. Even though an exact date
for this ￿event￿is hard to pinpoint, some authors have argued that the e¢ cacy and di⁄usion
of medicine in the start of the 20th century were weak￿ see, among others, McKeown (1972)
and Caldwell (1992). Accordingly, I test for a correlation between genetic distance and life
expectancy in 1900 and, as Section 6 shows, there seems to be no correlation at that period of
time.
Finally, the choice of the US as health frontier should be motivated. First, this is the
selection of Spolaore and Wacziarg (2009) as frontier for new technologies in general. Second,
Kremer (2002) reports that the US pharmaceutical market accounts for 39.9 percent of the
world market in 1998. Third, Papageorgiou et al. (2007, p.411) argue that the US, with nine
other Western countries, ￿supply the bulk of medical products and carry out the vast majority
of medical R&D￿ . Notice, if a di⁄erent country in that group was considered as frontier in
the analysis below, e.g. UK, then similar results are obtained as this group of countries is
genetically near the US (see Figure 1).5
The following section places the hypothesis in a theoretical context.
5This holds for all countries in the group except for Japan. The ten countries are: Belgium, France, Germany,
Italy, Japan, Netherlands, Sweden, Switzerland, UK, and US.
52.1 Theoretical model
This section constructs a simple theoretical overlapping generations model in order to illustrate
the hypothesis in a theoretical context. The proposed model draws on the ideas from the
endogenous longevity literature (see Philipson and Becker, 1998; Chakraborty, 2004) which ￿ts
the purpose of supporting the empirical counterpart well
In this model, agents in country i live for two periods, denoted by the ￿rst and second
period, respectively. All agents born at time t have a probability of Xit+1 2]0;1) of surviving
to the second period. The probability of survival, Xit+1, depends upon health investments, hit,
made in the ￿rst period, the di⁄usion of new health technologies ￿h(1 ￿ ￿di), where ￿h > 0
denotes new health technologies discovered at the frontier, di is genetic distance to the frontier
and ￿ is a positive constant ensuring that ￿di 2 (0;1). Hence, in accordance with the proposed
hypothesis, I assume that health inventions are realizable (and exogenous) to country i but
it is the interaction with cultural/biological divergence to the frontier that determines the
e⁄ectiveness in reducing mortality.
The survival probability also depends on the former generation￿ s level of health, indicated







where ￿;￿ 2 (0;1) and I have, additionally, assumed a particular functional relationship among
the health inputs. Accordingly, it is assumed that health technologies complement private
health investment￿ where private health investments, hit, can be thought of in terms of basic
nutrition (calorie intake) and care. That is, new health technologies make private health invest-
ments more productive in increasing survivability. Nevertheless, the e¢ cacy of this interaction
rest on genetic distance, di, to the frontier.
In the working period, agents supply one unit of labor endowment and earns a wage income
of wit which is divided between savings, sit, for second period consumption, cit+1, and private
health investment, hit. In the economy, there exists a perfect annuity market which distributes
the savings of those who die prematurely toward members of the same generation. The periodic
budget constraints therefore becomes:





The gross real rate of interest, earned in the domestic capital market, is denoted by Rit+1. The









0 < ￿ < 1 is the coe¢ cient of constant relative risk aversion.6 The representative agent
maximizes eq. (4) subject to eqs. (1)-(3) which produces the following closed form solutions:
hit =
￿




1 ￿ ￿ + ￿
wit. (6)





where ￿ 2 (0;1) is the capital share, ki;t is capital per worker and Ai is determined by new
technologies, also discovered at the frontier, and the ability to di⁄use them:
Ai = e
￿y(1￿￿di), (8)
￿y is new technologies other than health technologies, ￿ > 0 ensures that ￿di 2 (0;1). Notice,
eq. (8) is along the lines developed in Spolaore and Wacziarg (2009).
6The assumption 0 < ￿ < 1 implies that the ￿ ow utility is positive which ensures a meaning full solution for
health investments. As an alternative, one could add a positive constant, ensuring that the ￿ ow utility will be
positive, and only assume that 0 < ￿, as it is normally assumed. However, this implies that I can not obtain a
closed solution. For more on this issue, in general, see e.g., Hall and Jones (2007).
7Assuming that factors are paid by their marginal products and capital depreciates fully
within one period yields the usual conditions:






The ￿nal element of the model is the capital market clearing condition kit+1 = sit.7
Using eqs. (1)-(10), the subsequent expression for the survival rate can be obtained:
lnXit+1 = ￿(￿h￿ + ￿y￿￿)di + ￿￿lnkit + ￿ lnXit + ￿h + ￿y + ln
￿(1 ￿ ￿)
1 ￿ ￿ + ￿
. (11)
This equation shows that genetic distance lowers the survival rate by means of two channels.
The ￿rst channel is the interaction with new health technologies, which, as mentioned above,
is empathized by many scholars to be important. The second channel operates through in-
come, because genetic distance captures the ability to di⁄use other technologies as well, it also
in￿ uences the wealth of the economy and thereby health￿ wealthier is healthier in this simple
model. But the hypothesis under investigation is captured only by the ￿rst channel. Thus,
in estimating the e⁄ect of di⁄using health technologies on health, a trade-o⁄ between omitted
variable and reverse causality bias emerges. Indeed, by the inclusion of income as control,
the second channel can be eliminated￿ reducing omitted variable bias￿ but this strategy rises the
problem of reversed causality. Although, I admittedly have no perfect solution for this dilemma,
I attempt to deal with this in two way. First, I estimate the e⁄ect without income but with
some exogenous geographical controls know to be important determinants of income. Second,
I include income but in order to minimize the risk of reverse causality, income is include with
a time lag.
Since genetic distance (d) is fairly constant over a 100-year period, a time increasing e⁄ect of
genetic distance on the survival rate (X) is evidence of that ￿h increases over time which then
signi￿es the development of new health technologies and/or globalization of health technologies.
In the start of the empirical analysis, I assume that ￿ = 0 and estimate the level equation.
Later on the growth approach is pursued.
7Thus, it is assumed that international capital ￿ ows are restricted and international health knowledge is not.
This is only a modelling assumption which is not crucial for my theoretical results.
8Finally, while there certainly are several other factors in￿ uencing mortality outcomes, eq.
(11) is merely meant to clarify the proposed hypothesis. In fact, the empirical analysis below
includes a range of other controls not given in eq. (11).
3 Estimating framework
The primary estimation framework can be derived from the theoretical model. The estimation
equation therefore follows from eq. (11):
lnXijt = ￿ + ￿di + ￿
0Zit + ￿k + ￿ijt, (12)
Xijt is a measure of health status in the ith country by three indicators, j = 1;2;3: life
expectancy at birth, infant survival rate and adult survival rate in period t where the initial
focus is on the year 2000.
The genetic distance from country i to the US is given by di. For future reference, the
genetic distance between country 1 and 2 relative to the US is D12 ￿j d1 ￿ d2 j.
Zi denotes a set of other controls (see below), ￿k￿ s denote a full set of continent dummies
and, ￿nally, ￿ijt is the disturbance term. Again, the hypothesis under investigation is ￿ < 0.
Because genetic, geographic and linguistic distance to the US are likely to be correlated and
all potentially in￿ uence the outcome variables, Zi8t always includes physical distance to the
US and a dummy equal to one if the main language is English.
4 The data
This section describes the dataset assembled to perform the empirical analysis.8
The main dependent variables I seek to explain are three mortality outcomes in the year
2000, as already indicated, these are: life expectancy at birth, infant and adult survival rates,
in that order. The distinction is made because it reveals some interesting insights.
8Data sources and further details of all variables are given in the data Appendix and a cross correlation
matrix for the most important variables is depicted in Table 7 Appendix A.
9The key explanatory variable is the current genetic distance to the US (d). This variable
is constructed on the basis of genetic distance between world populations from Cavalli-Sforza
et al. (1994) and was matched to countries by Spolaore and Wacziarg (2009), using ethnic
composition data, in the 1990s, from Alesina et al. (2003). Genetic distance can, in principle,
be converted into time elapsed since the two populations shared a common ancestor population.
One can, to some extent, compare genetic distance to a variable such as latitude. Geographic
gradients in income or disease rates are well-known in the literature. However, it is obviously
not the geographic location (e.g., latitude), per se, that is causally related to the gradients but
rather a host of underlying variables like sunlight (Andersen et al., 2010), temperature, rainfall
and so on. By the same token, genetic distance is based on comparison of neutral genes (think
of eye-color). Nonetheless, the underlying variable, captured by genetic distance, is a measure
of long-term divergence which I hypothesize to, especially, e⁄ect the ability to di⁄use health
technologies. Of course, opposed to latitude, genetic distance is in￿ uenced by human behavior
in the very long run (migration). Nevertheless, in the short run the variable is reasonably
exogenous to human-economic activities. A world map visualizing the genetic distance to the
US is given in Figure 1.9






Genetic distance to the US
Data source: Spolaore and Wacziarg (2009)
9For a nice comprehensive description of the genetic distance variable see Spolaore and Wacziarg (2009).
10Because the current ethnic composition may be endogenous to mortality￿ in the long run￿ I
follow the approach by Spolaore and Wacziarg (2009) and utilizes the historic genetic distance,
as of 1500 CE, to England as instrument for the current genetic distance to the US.
For exogenous controls, I use a range of geographically related variables, re￿ ecting di⁄erent
aspects of geography. Additional controls include a range of other variables accounting for
socioeconomic country characteristics and historical variables for early development. Overall,
the control variables are introduced as the analysis progresses (all control variables are also
described in the Data appendix).
5 Regression results
The ￿rst four columns of Table 1 report the estimates when the dependent variable is life
expectancy in 2000. Column (1) shows that in absence of any controls,10 there is a highly
signi￿cant negative e⁄ect of genetic distance to the US. Taken at face value, the size of the
coe¢ cient implies that a one-standard-deviation increase in genetic distance to the US is as-
sociated with a decline in life expectancy of 13.6%￿ equal to a 76.7% of a standard deviation
decrease in life expectancy. Column (2) includes continent ￿xed e⁄ect and the magnitude of the
coe¢ cient on genetic distance is reduced by around 39 percent which is to be expected. That
is, the coe¢ cient in the ￿rst speci￿cation is capturing that countries within a given continent
are genetically more similar.11
To capture geographical factors simultaneous in￿ uence on genetic distance and life ex-
pectancy, column (3) includes exogenous geographical controls. First, share of land in tropics
(TROP) is included due to the well-known gradient in disease rates (Bloom and Sachs, 1998)
and since TROP is more prevalent in some geographical areas than others, it likely correlates
with genetic distance to the US. Second, other aspects of geography may indirectly impact
health through income, to circumvent this, column (3) also includes log mean distance to cost
or river (DISTCR) and percentage of arable land (ARAB). Consistently, the inclusion of these
geographical controls reduces the magnitude of genetic distance to the US on life expectancy a
10Besides the log distance to Washington D.C and a dummy equal to one if the main language is English.



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































12little but the negative relationship remains highly signi￿cant and is still large in magnitude.12
To isolate the e⁄ects of the proposed channel, I now include log income per capita (GDPPC).
But in order to lower the risk of reverse causation, I use GDPPC from 1990. Column (4) takes
GDPPC into account, the e⁄ect of genetic distance decrease only slightly in magnitude and
income per capita has the expected positive signi￿cant e⁄ect on life expectancy.13
The results, thus far, suggest that there exists a sizeable negative e⁄ect of genetic distance to
the US on life expectancy. In particular, a one-standard-deviation increase in genetic distance
is associated with a 5.3% decline in life expectancy equivalent to 28.8% of a standard deviation
decrease in life expectancy.
Pritchett and Summers (1996) ￿nd the cross country relationship between the infant survival
rate and income level to be particularly strong whereas the relationship between life expectancy
and income is not. Those observations hint that it might be interesting to study the e⁄ect
of genetic distance on the infant and adult survival rates separately. In columns (5) and
(6), the dependent variables are the infant and adult survival rate, respectively, otherwise
the speci￿cations are similar to that of column (4). Both speci￿cations have the expected
negative signs, implying that genetic distance to the US is associated with a negative e⁄ect
on survivability. However, the magnitude on the infant survival rate is rather small and is
only signi￿cant at the 10% level while the e⁄ect on adult survival is ￿large￿in magnitude and
highly signi￿cant (also compare the standardized beta coe¢ cients on genetic distance reported
in Table 1). For the adult survival rate, a one-standard-deviation increase in genetic distance
is associated with a 55.6% of a standard deviation decrease in the adult survival rate. Figure
2 plots the partial correlation between the adult survival rate and genetic distance￿ the health
gradient in genetic distance￿ and it shows that the result is not driven by a small number of
unimportant countries or outliers.14
12Similar results are obtained if I, alternatively, include absolute di⁄erences to the U.S. for the geography
variables (results available upon request).
13I have also tried to include average year of schooling in the workforce, from Baier et al. (2006), as a measure
for economic development. This does, however, not change any of the results. Irrespectively of the problems
with reverse causation, I have also tried to included log income per capita in 2000 (instead of 1990), which
increases the number of observations, again similar results are obtained.
14From Figure 2 one might infer that Zimbabwe (ZWE) is an outlier. However, dropping this observation
13As a whole, the results imply that genetic distance to the US mostly in￿ uences life ex-
pectancy through the adult survival rate and not the infant survival which instead seems to
be more sensitive to log income per capita (GDPPC). The fact that genetic distance has no
signi￿cant impact on the infant survival rate is also in line with an argument put forward in
Acemoglu and Johnson (2007, p.951). Indeed, they argue that their instrument for health
(medical inventions) is not that strongly related to infant survival because the main medical
discoveries in the 1940-200 period mainly a⁄ected adult survivability.
Last, I address the issue that the current ethnic composition of the US could be evidence
of some omitted variable that also in￿ uences survival directly. Column (7) presents the two-
stage-least square result for the adult survival rate where I use historic genetic distance in
1500 to England as instrument (dHIST). The estimate of the genetic distance variable remains
statistically signi￿cant at the 1% level, and is larger than those obtained with OLS.15





































































































































































-.1 -.05 0 .05 .1
e( Genetic distance to the US | X )
coef = -2.111, (robust) se = .340, t = -6.2
Data source: Column 6 of Table 1
Overall, the results in Table 1 point to an impact of genetic distance to the US on life
does not a⁄ect the result noticeable. See Figure 3 in Appendix A, for the corresponding partial plot without
Zimbabwe.
15Which, as usual, suggests that measurement error in the ethnic composition, creating attenuation bias, is
likely to be more important than omitted variables biases.
14expectancy at birth which is primarily driven by its impact on adult survivability.
The rest of the paper is devoted to establish the robustness of this result.
6 Robustness check
Encouraged by the previous section, the speci￿cation most compatible with the proposed
hypothesis￿ and most loyal to the theoretical model in section 2.1￿ is the one with the adult
survival rate as the measure for health. For this reason, the robustness analysis revolves around
this model.
In general, this section demonstrates a remarkably robustness of genetic distance on adult
survivability over the period 1960-2000. Moreover, it reveals that genetic distance has no
association with life expectancy in the year 1900 which supports the technological interpretation
of the correlation between genetic distance and mortality outcomes.
Additional controls: The validity of my results, obtained so far, depends on the assump-
tion that no omitted variable a⁄ects the adult survival rate and at the same time correlates
with genetic distance to the US. For this reason, I now substantiate further the robustness of
the result by including additional controls. Notice, because the last section established that the
health gradient in genetic distance is not due to the income channel and because of reversed
causation, the robustness analysis refrains form including GDPPC in any of the following spec-
i￿cations.
In Table 2 additional geographical and historical controls are included. First, I check whether
my particular choice of measure for geography in￿ uences the results. While proportion of land
in the tropics (TROP) and absolute latitude (ALAT) are highly correlated, ALAT may be
more appropriate for the idea that technology normally di⁄uses more easily at same latitudes.
Furthermore, whether countries are landlocked (LOCK) may be related to the ability to di⁄use
new health technologies, seeing that such countries, in general, have di¢ cult access to the
outside world (Soares, 2007). In column (1) and (2) these variables are included separately and
in Column (3) all geographical variables, considered, are included together. My estimates of
the e⁄ect of genetic distance on adult survivability remains negative a highly signi￿cant.16






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































16Second, for the reason that genetic distance is a measure of time elapsed since two popula-
tions has been one, genetic similar countries are more likely to share the same economic history,
an aspect which might directly impact adult survivability. Although the inclusion of income
per capita, in the previous section, is intended to capture some of this matter, it might not suf-
￿ce. For example, genetic similar countries may have made the transition to agriculture earlier
than countries which are genetically distant. In previous studies, the timing of the Neolithic
Revolution has been shown to be crucial for early economic development (Ashraf and Galor,
2010a). But an early Neolithic Revolution need not to be associated with higher per capita
income today (Galor, 2011). Still, early development might in￿ uence contemporary health per-
formance. For example, up to 25% of European American is, to some extent, protected against
HIV infection and progression while this is not the case for other ethnic groups (Stephens et al.,
1998). One may reason that this is due to the European American-population long-term history
of living in more densely populated areas which, in essence, is the hypothesis put forward by,
Galor and Moav (2007). However, genetic distance to the US might also pick this up because it
measures ethnic and racial ancestry. Therefore, I now include controls for early development.
As a measures for early development I use: log population density of year 1500 CE (LPD), an
index for state history from 0 to 1500 CE (STAT), the onset (date) of the demographic/fertility
transition (FERT) and the timing of the Neolithic revolution (NRW). As already mentioned,
the latter variable is used in Galor and Moav (2007) to test their hypothesis. Column (4)-(7)
expand upon these variables of early development but they only have a negligible e⁄ect on my
estimate of genetic distance to the US.17
Previous studies have shown that ethnic and linguistic diversity, within a country, have
an adverse e⁄ect on growth and redistribution (Easterly and Levine, 1997; Alesina et al.,
1997 and Desmet et al., 2008) potentially in￿ uencing survivability through the provision of
public health. These observations, together with the result in Ahelrup and Olsson (2009),
that ethnic diversity is related to genetic distance, make it worthwhile to include a measure
I include the absolute di⁄erence to the US (result available upon request).
17Also notice, the correlation between the timing of the Neolithic Revolution and genetic distance to the US
is rather high (-0.736, see Table 7). One interpretation of this correlation could be along the lines of Sokal et
al. (1991). They argued that agriculture in Europe was di⁄used by means of population migration, explaining
the correlation with the genetic makeup.
17of ethnolinguistic fractionalization (ELF). Column (1) of Table 3 includes ELF, importantly,
though, genetic distance is una⁄ected by this.
Besley and Kudamatsu (2006) point toward a link between health outcomes and democracy
across countries. Speci￿cally, the authors argue that democracies, in general, will be more
concerned with public health issues. Undoubtedly, genetic distance to the US and the level of
democracy is related. Column (2), therefore, includes a variable for the degree of democracy
prevailing in the country in the year 1990 (POLIT2).18 This does not change the coe¢ cient on
genetic distance and it con￿rms the results obtained in Besley and Kudamatsu (2006) that there
is a positive relation between democracy and health. As an additional measure of provision of
public health service, I include the share of population with access to safe water (WATER) in
column (3). This variable has the expected positive sign but the magnitude of genetic distance
remains una⁄ected.
Caldwell (1986) and Filmer and Pritchett (1999) ￿nd that religion is an important deter-
minant of infant mortality. Therefore column (4) includes that share of Muslims in a country
(MUSL) and the share of Catholics (CATH). Both variable have practically no impact on the
adult survival rate and, again, the genetic distance variable is una⁄ected.
Papageorgiou et al. (2007) emphasize the importance of medical technology di⁄usion on
health outcomes. Their study uses medical imports as a measure for the di⁄usion of medical
technology. For 66 medical-importing countries, the authors show that di⁄usion is an important
contributor to health performance as measured by cross country mortality rates. Column (7)
of Table 3 recreates their basic insight by demonstrating that medical import (MEDI) has a
signi￿cant positive e⁄ect on the adult survival rate. The regression in Column (8) reproduces
my basic result for this smaller sub-sample: genetic distance still has a negative e⁄ect on the
adult survival rate. Column (9) incorporates both variables and shows that the magnitude of
the coe¢ cient on MEDI is reduced substantial while the e⁄ect of genetic distance on adult
survivability is barely a⁄ected. This comparison, once more, suggests that genetic distance is
an important determinant of the adult survival rate.
Notice, I have also checked whether my results hinge on the inclusion of Sub-Saharan coun-
18As an alternative robustness check I have also tried to include an index for institutional quality (SOCIN),
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































19tries. Reassuringly, though, excluding those countries from the sample does not change my
results signi￿cantly.
A growth approach: Up to this point, I have studied the e⁄ect of genetic distance on the
level of the adult survival rate. As outlined, however, genetic distance might also in￿ uence the
growth rate of the survival rate. Table 4 pursues the growth approach by incorporating the log
of the adult survival rate in the year 1960 (lnX 60). The estimated coe¢ cients are consistent
with some conditional convergence, that is, a high initial survival rate subsequent reduces the
growth rate in this variable. More interestingly for the current analysis, genetic distance has
a signi￿cant negative impact on the growth of the adult survival rate in all speci￿cations.
For example, in column (3), one-standard-deviation increase in the genetic distance relative to
the US is associated with 43.6% of a standard-deviation decrease in the adult survival rate,
controlling for geographical, historical and economical characteristics.


















Standardized ￿ on d -0.508 -0.436
Cont. ￿xed e⁄ects YES YES
Notes: All regressions are estimated by OLS. Robust standard
errors in parentheses*** p<0.01, ** p<0.05, * p<0.1
20Alternative years: Now, I investigate the time varying e⁄ect of genetic distance on the
adult survival rate. Table 5 presents the results from this study where the same variation
in explanatory variables is exploited by restricting the samples. The important lesson from
column (1)-(5) is that the e⁄ect of being genetic distant from the US on the adult survival
rate is increasing over time. As argued, this is possibly evidence of an acceleration of new
medicine, new treatments and new health technologies and globalization which has made the
health gradient, in genetic distance, more steep.
Because of lack of data, column (6) and (7) utilize life expectancy at birth as dependent
variable, to compare the e⁄ect of genetic distance on health in start of the 20th century to the
end of the century. In column (6), the e⁄ect of genetic distance to the US in the year 1900 has
the wrong sign and is insigni￿cant. Whereas in 2000, column (7), the e⁄ect of genetic distance
has the correct hypothesized negative sign and is signi￿cant (using the same sample). Again, I
view this as support for the proposed hypothesis because the di⁄usion of international medical
knowledge is a precondition for genetic distance to in￿ uence mortality and this condition was,
to wide extent, not meet in start of 20th century.
7 Concluding remarks
This paper put forward empirical evidence for the hypothesis of a cross-country health gradient
in cultural and biological divergence to the technological health frontier. The idea behind this
type of health gradient is that long-term divergence interacts with the di⁄usion of modern
health technologies. The paper empirical documents that this health gradient is not primarily
operating through geographical, historical and other social economic factors.
As whole, the results support the conclusions made in Cutler et al. (2006, p.117). They
conclude that ￿...an acceleration in the production of new knowledge and new treatments is
likely to make the health gradient steeper, with increasing gaps across educational and social
class (occupational) groups, and possibly race as well. Gaps between countries may also widen￿ .
Indeed, the empirical evidence, presented here, suggests that the health gradient in cultural
divergence has become more steep and that there was no gradient at all in start of the 20th
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































22di⁄usion health technologies￿ which one can interpret as globalization of health technologies￿ in
determining cross-country health outcomes.
These ￿ndings add to debate of what determines health improvements at the national level.
They provide evidence for that scienti￿c breakthroughs matters to a great extent for adult
survivability while income per capita seems to matter lesser extent.
23Appendix A
Table 6￿ Life expectancy and income
Dependent variable:
Log life expectancy at birth
(1) (2) (3)
Log GDPPC 0.134*** 0.002
(0.0155) (0.0133)
Obs. 694 694 694
R2 0.264 0.678 0.678
Country FE YES YES YES
Time FE NO YES YES
Notes: countries are the level of observation with decennial time span. The
sample includes 193 countries and size of the constant is not reported. SD
errors are clustered at the country level: *** p<0.01, ** p<0.05, * p<0.1
Table 7￿ Cross-correlations
Variables d X3 X1 X2 GDPPC NRW
d 1.000
X3 -0.754 1.000
X1 -0.773 0.874 1.000
X2 -0.676 0.700 0.940 1.000
GDPPC -0.613 0.594 0.785 0.820 1.000
NRW -0.734 0.614 0.630 0.541 0.434 1.000
Notes: X1, X2 and X3 are measured in 2000 and GDPPC in 1990



































































































































































-.1 -.05 0 .05 .1
e( Genetic distance to the US | X )
coef = -1.911, (robust) se = .281, t = -6.81
Data source: Column 6 of Table 1 but without the observation Zimbabwe
Data appendix
Health:
X3;1960￿2000= The male adult survival rate. The probability of surviving to the age 60
conditioned on surviving to the age of 15 for the period 1960-2000. Source: World Bank￿ s
World Development Indicators.
X2;1960￿2000= The probability of an infant surviving to the age of one for the period 1960-
2000. Source: World Bank￿ s World Development Indicators.
X1;1960￿2000 = Expected length of life at birth for the period 1960-2000. Source: World
Bank￿ s World Development Indicators. Life expectancy in the year 1900 is taken from Acemoglu
and Johnson (2007).
Genetic:
d=Current genetic distance to the United States which may be interpreted as the time
since two populations have shared common ancestors. A higher d is associated with a larger
di⁄erence in genetic distribution. For a detailed description see Spolaore and Wacziarg (2009).
Source: Spolaore and Wacziarg (2009).
dHIST= Genetic distance to England as of 1500. Source: Spolaore and Wacziarg (2009).
25Geography:
ALAT = Absolute average latitude from Equator. Source: CIA World Factbook.
ARAB = Percentage of arable land. Source: World Bank￿ s World development indicators.
DISTCR = Nearest distance to coast line or river. Source: Gallup et al. (2001)
FROST = Proportion of land with more than ￿ve days of frost per year. Source: Master
and McMillan (2001).
Geodesic distance=distance between the major cities of the countries (in measure of the
great circle). Source: Centre d￿ Etudes Prospectives et d￿ Informations Internationales (CEPII).
TROP = Percentage of tropical land area. Source: Gallup et al. (2001)
LOCK = A dummy which takes on the values one if the country is landlocked and otherwise
zero. Source: Gallup et al. (2001)
Early development:
NRW = Weighted average of the time elapsed since the ancestors of the population of
each country in year 2000 went through the Neolithic Revolution in 1000 of years. For a more
detailed description see Galor and Moav (2007). Source: Putterman (2008).
NRU = Unweighted time elapsed since Neolithic Revolution in 1000 of years. Source:
Putterman (2008).
STAT = State Antiquity Index. The score re￿ ects the existence of a government, the pro-
portion of the territory covered, and whether it was indigenous or externally imposed. Source:
Putterman (2008)
LPD = Log population densities in 1500 CE. Source: McEvedy and Jones (1978)
FERT = The year of the beginning of the fertility transition which is arguably related to
the economic take o⁄. Source Rehr (2004).
Socioeconomic:
GDPPC = log of real GDP per capita in constant prices in the year 1990. Source: Penn
World Tables version 6.3.
SOCIN = An index taking on the value 0 to 1 on the social infrastructure in a given country.
Source: Hall and Jones (1998).
26POLIT2= a variable in the range -10-10 where a positive value indicated a democracy.
Source: The Polity IV Data Base
ELF= ethnolinguistic fractionalization index. Source: Fearon (2003)
WATER= Access to an improved water source refers to the percentage of the population
with reasonable access to an adequate amount of water from an improved source, such as
a household connection, public standpipe, borehole, protected well or spring, and rainwater
collection. Source: World Bank￿ s World Development Indicators.
MEDI= Medical imports is the sum of pharmaceutical, medical, and other health-related
imports. Source: Papageorgiou et al. (2007)
HIV= Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with
HIV. Source: World Bank￿ s World Development Indicators
MUSL= Share of Muslims in a given country in 1980. Source: Acemoglu et al. (2001)
CATH= Share of Catholics in a given country in 1980. Source: Acemoglu et al. (2001)
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